Cargando…
A novel mouse strain optimized for chronic human antibody administration
Therapeutic human IgG antibodies are routinely tested in mouse models of oncologic, infectious, and autoimmune diseases. However, assessing the efficacy and safety of long-term administration of these agents has been limited by endogenous anti-human IgG immune responses that act to clear human IgG f...
Autores principales: | Gupta, Aaron, Smith, Patrick, Bournazos, Stylianos, Ravetch, Jeffrey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915995/ https://www.ncbi.nlm.nih.gov/pubmed/35235456 http://dx.doi.org/10.1073/pnas.2123002119 |
Ejemplares similares
-
The role of IgG Fc receptors in antibody-dependent enhancement
por: Bournazos, Stylianos, et al.
Publicado: (2020) -
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
por: Bournazos, Stylianos, et al.
Publicado: (2020) -
Synthetic nanobodies as tools to distinguish IgG Fc glycoforms
por: Kao, Kevin S., et al.
Publicado: (2022) -
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies
por: Casey, Emily, et al.
Publicado: (2017) -
The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
por: Bournazos, Stylianos, et al.
Publicado: (2015)